313 related articles for article (PubMed ID: 28751467)
1. Recurrent Thrombosis in Patients with Antiphospholipid Syndrome Receiving Newer Oral Anticoagulants: A Case Report and Review of Literature.
Joshi A; Hong J; Siva C
Clin Med Res; 2017 Jun; 15(1-2):41-44. PubMed ID: 28751467
[TBL] [Abstract][Full Text] [Related]
2. Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature.
Dufrost V; Risse J; Zuily S; Wahl D
Curr Rheumatol Rep; 2016 Dec; 18(12):74. PubMed ID: 27812956
[TBL] [Abstract][Full Text] [Related]
3. Thrombotic events in patients with antiphospholipid syndrome treated with rivaroxaban: a series of eight cases.
Signorelli F; Nogueira F; Domingues V; Mariz HA; Levy RA
Clin Rheumatol; 2016 Mar; 35(3):801-5. PubMed ID: 26219490
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral anticoagulants. Results from an international patient-level data meta-analysis.
Dufrost V; Risse J; Reshetnyak T; Satybaldyeva M; Du Y; Yan XX; Salta S; Gerotziafas G; Jing ZC; Elalamy I; Wahl D; Zuily S
Autoimmun Rev; 2018 Oct; 17(10):1011-1021. PubMed ID: 30103045
[TBL] [Abstract][Full Text] [Related]
5. Direct oral anticoagulants in antiphospholipid syndrome: a real life case series.
Betancur JF; Bonilla-Abadía F; Hormaza AA; Jaramillo FJ; Cañas CA; Tobón GJ
Lupus; 2016 May; 25(6):658-62. PubMed ID: 26743321
[TBL] [Abstract][Full Text] [Related]
6. Direct oral anticoagulants: an alternative treatment for thrombotic antiphospholipid syndrome?
Resseguier AS; Pereira B; Rieu V; Le Guenno G; Grobost V; Ruivard M
Lupus; 2017 Oct; 26(12):1297-1303. PubMed ID: 28355988
[TBL] [Abstract][Full Text] [Related]
7. Use of direct oral anticoagulants in antiphospholipid syndrome.
Cohen H; Efthymiou M; Isenberg DA
J Thromb Haemost; 2018 Jun; 16(6):1028-1039. PubMed ID: 29624847
[TBL] [Abstract][Full Text] [Related]
8. The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome.
Malec K; Góralczyk T; Undas A
Thromb Res; 2017 Apr; 152():93-97. PubMed ID: 27989533
[TBL] [Abstract][Full Text] [Related]
9. Direct oral anticoagulants versus warfarin in patients with single or double antibody-positive antiphospholipid syndrome.
Williams B; Saseen JJ; Trujillo T; Palkimas S
J Thromb Thrombolysis; 2022 Jul; 54(1):67-73. PubMed ID: 34817786
[TBL] [Abstract][Full Text] [Related]
10. Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome.
Pengo V; Denas G; Zoppellaro G; Jose SP; Hoxha A; Ruffatti A; Andreoli L; Tincani A; Cenci C; Prisco D; Fierro T; Gresele P; Cafolla A; De Micheli V; Ghirarduzzi A; Tosetto A; Falanga A; Martinelli I; Testa S; Barcellona D; Gerosa M; Banzato A
Blood; 2018 Sep; 132(13):1365-1371. PubMed ID: 30002145
[TBL] [Abstract][Full Text] [Related]
11. Direct oral anticoagulants in hypercoagulable states.
Kunk PR; Brown J; McShane M; Palkimas S; Gail Macik B
J Thromb Thrombolysis; 2017 Jan; 43(1):79-85. PubMed ID: 27632140
[TBL] [Abstract][Full Text] [Related]
12. Recurrent Thrombosis With Direct Oral Anticoagulants in Antiphospholipid Syndrome: A Systematic Literature Review and Meta-analysis.
Sanchez-Redondo J; Espinosa G; Varillas Delgado D; Cervera R
Clin Ther; 2019 Sep; 41(9):1839-1862. PubMed ID: 31405527
[TBL] [Abstract][Full Text] [Related]
13. Diagnostics and treatment of thrombotic antiphospholipid syndrome (APS): A personal perspective.
Pengo V; Denas G
Thromb Res; 2018 Sep; 169():35-40. PubMed ID: 30007134
[TBL] [Abstract][Full Text] [Related]
14. Direct oral anticoagulants in antiphospholipid syndrome: Meta-analysis of randomized controlled trials.
Dufrost V; Wahl D; Zuily S
Autoimmun Rev; 2021 Jan; 20(1):102711. PubMed ID: 33197580
[TBL] [Abstract][Full Text] [Related]
15. Cessation of oral anticoagulants in antiphospholipid syndrome.
Comarmond C; Jego P; Veyssier-Belot C; Marie I; Mekinian A; Elmaleh-Sachs A; Leroux G; Saadoun D; Oziol E; Fraisse T; Hyvernat H; Thiercein-Legrand MF; Sarrot-Reynauld F; Ferreira-Maldent N; de Menthon M; Goujard C; Khau D; Nguen Y; Monnier S; Michon A; Castel B; Decaux O; Piette JC; Cacoub P
Lupus; 2017 Oct; 26(12):1291-1296. PubMed ID: 28355985
[TBL] [Abstract][Full Text] [Related]
16. Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome: Study Rationale and Design (ASTRO-APS).
Woller SC; Stevens SM; Kaplan DA; Branch DW; Aston VT; Wilson EL; Gallo HM; Johnson EG; Rondina MT; Lloyd JF; Evans RS; Elliott CG
Clin Appl Thromb Hemost; 2016 Apr; 22(3):239-47. PubMed ID: 26566669
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial.
Pengo V; Banzato A; Bison E; Zoppellaro G; Padayattil Jose S; Denas G
Lupus; 2016 Mar; 25(3):301-6. PubMed ID: 26466613
[TBL] [Abstract][Full Text] [Related]
18. [Warfarin in the treatment of antiphospholipid syndrome].
Reshetniak TM; Kondrat'eva LV; Patrusheva NL; Patrushev LI
Ter Arkh; 2007; 79(5):47-54. PubMed ID: 17672075
[TBL] [Abstract][Full Text] [Related]
19. Recurrent venous thrombosis despite 'optimal anticoagulation therapy' for antiphospholipid syndrome--could new oral anticoagulants solve the problem?
Balaban M; Stanrić V; Rincić G; Ledinsky M; Grbac L; Stancić N; Tomasić H
Acta Clin Croat; 2010 Dec; 49(4):469-77. PubMed ID: 21830460
[TBL] [Abstract][Full Text] [Related]
20. Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5.
Ruiz-Irastorza G; Khamashta MA; Hunt BJ; Escudero A; Cuadrado MJ; Hughes GR
Arch Intern Med; 2002 May; 162(10):1164-9. PubMed ID: 12020188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
